| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |